Immulogix, LLC to Receive Exclusive Patent License for Carriogenic Immunodiagnostic Assays

Summary

The US Department of the Navy has announced its intention to grant Immulogix, LLC a non-exclusive, revocable license to practice worldwide a portfolio of Government-owned patents related to the development of cariogenic immunodiagnostic assays, with the first patent issued in 1990.